Verified Nov 2026
Other
·

Aprilia, Lazio
·
Since 1918
IBI - Istituto Biochimico Italiano Giovanni Lorenzini is a pharmaceutical manufacturer headquartered in Aprilia, Lazio, Italy, founded in 1918. The company employs 200–500 people and generates estimated revenue of $50–100 million annually. It specializes in aseptic manufacturing of sterile injectable medicinal products, including penicillins and β-lactam antibiotics, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. The company was acquired by ACS Dobfar in July 2026.
IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. at a glance
Revenue
$50-100M
Est. band
Employees
200-500
Founded
1918
Headquarters
Aprilia, Lazio
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
IBI - Istituto Biochimico Italiano Giovanni Lorenzini is a pharmaceutical manufacturer headquartered in Aprilia, Lazio, Italy, founded in 1918. The company employs 200–500 people and generates estimated revenue of $50–100 million annually. It specializes in aseptic manufacturing of sterile injectable medicinal products, including penicillins and β-lactam antibiotics, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. The company was acquired by ACS Dobfar in July 2026.
At a glance
Attribute | Detail |
|---|---|
Founded | 1918 |
Headquarters | Aprilia, Lazio |
Employees | 200-500 |
Revenue | $50-100M (estimated) |
What IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. makes
The company provides contract manufacturing and development services covering aseptic filling, sterile finished-product manufacturing under GMP standards, and advanced formulations including micro- and nanoparticle drug-delivery systems.
Latest developments
2026-08-03 — LCA Studio Legale nell'operazione di acquisizione dell'Istituto Biochimico Italiano G. Lorenzini da parte di ACS Dobfar | LCA Studio Legale (lcalex.it)
2026-07-24 — IBI Lorenzini passa ad ACS Dobfar. Gli advisor (financecommunity.it)
2026-07-23 — Acs Dobfar acquisisce l’Istituto Biochimico Italiano G. Lorenzini - FarmaciaVirtuale.it (farmaciavirtuale.it)
2026-07-23 — Ibi Lorenzini passa ad Acs Dobfar: salvi i posti di lavoro ad Aprilia | Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco (fedaiisf.it)
2026-07-22 — Istituto Biochimico Italiano G. Lorenzini cambia proprietà (ibi-lorenzini.it)
2026-07-22 — Acs Dobfar acquisisce Istituto Biochimico Italiano Lorenzini (innlifes.com)
Company details
Established over 100 years ago, IBI maintains significant production facilities in the UK, Germany, and Italy, and is recognized for injectable medicinal products supplied to hospitals across multiple regions. IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. was founded in 1918, has an estimated 200-500 employees, and is headquartered in Aprilia, Lazio.
Frequently asked questions
What does IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. do?
IBI - Istituto Biochimico Italiano Giovanni Lorenzini is a pharmaceutical manufacturer headquartered in Aprilia, Lazio, Italy, founded in 1918. The company employs 200–500 people and generates estimated revenue of $50–100 million annually. It specializes in aseptic manufacturing of sterile injectable medicinal products, including penicillins and β-lactam antibiotics, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. The company was acquired by ACS Dobfar in July 2026.
Where is IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. headquartered?
IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. is headquartered in Aprilia, Lazio (2 Via Fossignano, Aprilia, Lazio, 04011).
When was IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. founded?
IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. was founded in 1918.
How big is IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a.?
IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. has an estimated 200-500 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
